Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.690
-0.030 (-1.74%)
At close: Apr 28, 2026, 4:00 PM EDT
1.700
+0.010 (0.59%)
After-hours: Apr 28, 2026, 7:16 PM EDT
Tempest Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 13.97 | 13.55 | 11.66 | 12.11 | 9.82 | |
| Research & Development | 12.61 | 28.48 | 17.5 | 22.53 | 17.17 | |
| Operating Expenses | 26.58 | 42.03 | 29.16 | 34.64 | 26.99 | |
| Operating Income | -26.58 | -42.03 | -29.16 | -34.64 | -26.99 | |
| Interest Expense | -0.21 | -1.32 | -1.45 | -1.62 | -1.28 | |
| Interest & Investment Income | 0.52 | 1.5 | 1.12 | 0.55 | - | |
| Other Non Operating Income (Expenses) | - | - | - | - | -0.03 | |
| Pretax Income | -26.26 | -41.84 | -29.49 | -35.71 | -28.3 | |
| Net Income | -26.26 | -41.84 | -29.49 | -35.71 | -28.3 | |
| Net Income to Common | -26.26 | -41.84 | -29.49 | -35.71 | -28.3 | |
| Shares Outstanding (Basic) | 4 | 2 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 4 | 2 | 1 | 1 | 0 | |
| Shares Change (YoY) | 93.35% | 80.99% | 33.49% | 204.70% | 709.63% | |
| EPS (Basic) | -6.33 | -19.50 | -24.87 | -40.20 | -97.07 | |
| EPS (Diluted) | -6.33 | -19.50 | -24.87 | -40.20 | -97.07 | |
| Free Cash Flow | -26.82 | -33.46 | -27.53 | -31.63 | -26.09 | |
| Free Cash Flow Per Share | -6.46 | -15.59 | -23.21 | -35.61 | -89.49 | |
| EBITDA | -26.31 | -41.64 | -28.78 | -34 | -26.61 | |
| D&A For EBITDA | 0.27 | 0.39 | 0.38 | 0.64 | 0.37 | |
| EBIT | -26.58 | -42.03 | -29.16 | -34.64 | -26.99 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.